Pao Novatek Stock Price To Sales
PAO NOVATEK fundamentals help investors to digest information that contributes to PAO NOVATEK's financial success or failures. It also enables traders to predict the movement of PAO Pink Sheet. The fundamental analysis module provides a way to measure PAO NOVATEK's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAO NOVATEK pink sheet.
PAO |
PAO NOVATEK Company Price To Sales Analysis
PAO NOVATEK's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current PAO NOVATEK Price To Sales | 0.06 X |
Most of PAO NOVATEK's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PAO NOVATEK is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, PAO NOVATEK has a Price To Sales of 0.0629 times. This is 96.43% lower than that of the Energy sector and 97.72% lower than that of the Oil & Gas E&P industry. The price to sales for all United States stocks is 99.45% higher than that of the company.
PAO Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAO NOVATEK's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PAO NOVATEK could also be used in its relative valuation, which is a method of valuing PAO NOVATEK by comparing valuation metrics of similar companies.PAO NOVATEK is currently under evaluation in price to sales category among its peers.
PAO Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0772 | |||
| Profit Margin | 0.41 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 68.11 B | |||
| Shares Outstanding | 3 B | |||
| Shares Owned By Insiders | 41.09 % | |||
| Shares Owned By Institutions | 2.44 % | |||
| Price To Earning | 2.22 X | |||
| Price To Book | 2.16 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 1.16 T | |||
| Gross Profit | 461.16 B | |||
| EBITDA | 562.38 B | |||
| Net Income | 432.93 B | |||
| Cash And Equivalents | 107.68 B | |||
| Cash Per Share | 358.59 X | |||
| Total Debt | 67.01 B | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 2.66 X | |||
| Book Value Per Share | 6,324 X | |||
| Cash Flow From Operations | 419.47 B | |||
| Earnings Per Share | 2.35 X | |||
| Number Of Employees | 10 | |||
| Beta | -33.61 | |||
| Market Capitalization | 66.78 B | |||
| Total Asset | 2.46 T | |||
| Annual Yield | 0.07 % | |||
| Net Asset | 2.46 T | |||
| Last Dividend Paid | 714.4 |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in PAO Pink Sheet
If you are still planning to invest in PAO NOVATEK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PAO NOVATEK's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |